Alexander Nowak
Stock Analyst at Craig-Hallum
(3.35)
# 836
Out of 4,814 analysts
48
Total ratings
41.67%
Success rate
5.38%
Average return
Main Sectors:
Stocks Rated by Alexander Nowak
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| CVRX CVRx, Inc. | Maintains: Buy | $20 → $22 | $6.25 | +252.00% | 5 | Jan 17, 2025 | |
| NTRA Natera | Maintains: Buy | $121 → $157 | $148.08 | +6.02% | 4 | Nov 13, 2024 | |
| BVS Bioventus | Maintains: Buy | $12 → $17 | $7.81 | +117.81% | 6 | Sep 27, 2024 | |
| QDEL QuidelOrtho | Upgrades: Buy | $40 → $57 | $25.15 | +126.64% | 6 | Sep 5, 2024 | |
| CELC Celcuity | Assumes: Buy | $25 → $27 | $10.22 | +164.19% | 2 | May 16, 2024 | |
| CDNA CareDx | Upgrades: Buy | $12 → $15 | $17.59 | -14.72% | 3 | May 1, 2024 | |
| DMAC DiaMedica Therapeutics | Assumes: Buy | $8 | $3.53 | +126.63% | 4 | Apr 24, 2024 | |
| AXDX Accelerate Diagnostics | Maintains: Hold | $2 → $1 | $0.54 | +84.84% | 3 | Apr 1, 2024 | |
| LUNG Pulmonx | Initiates: Buy | $18 | $4.52 | +298.23% | 1 | Sep 5, 2023 | |
| TNDM Tandem Diabetes Care | Maintains: Buy | $74 → $50 | $16.86 | +196.65% | 2 | Jun 13, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $14 → $8 | $0.75 | +970.38% | 1 | May 12, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | n/a | $41.59 | - | 1 | Oct 19, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | n/a | $0.58 | - | 2 | Mar 28, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $11 | $1.83 | +501.09% | 1 | Jan 5, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $88 → $110 | $51.07 | +115.39% | 3 | Feb 3, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Sell | n/a | $0.61 | - | 2 | Jan 20, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $300 | $2.00 | +14,900.00% | 1 | Jan 11, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $28 | $4.88 | +473.77% | 1 | Aug 31, 2020 |
CVRx, Inc.
Jan 17, 2025
Maintains: Buy
Price Target: $20 → $22
Current: $6.25
Upside: +252.00%
Natera
Nov 13, 2024
Maintains: Buy
Price Target: $121 → $157
Current: $148.08
Upside: +6.02%
Bioventus
Sep 27, 2024
Maintains: Buy
Price Target: $12 → $17
Current: $7.81
Upside: +117.81%
QuidelOrtho
Sep 5, 2024
Upgrades: Buy
Price Target: $40 → $57
Current: $25.15
Upside: +126.64%
Celcuity
May 16, 2024
Assumes: Buy
Price Target: $25 → $27
Current: $10.22
Upside: +164.19%
CareDx
May 1, 2024
Upgrades: Buy
Price Target: $12 → $15
Current: $17.59
Upside: -14.72%
DiaMedica Therapeutics
Apr 24, 2024
Assumes: Buy
Price Target: $8
Current: $3.53
Upside: +126.63%
Accelerate Diagnostics
Apr 1, 2024
Maintains: Hold
Price Target: $2 → $1
Current: $0.54
Upside: +84.84%
Pulmonx
Sep 5, 2023
Initiates: Buy
Price Target: $18
Current: $4.52
Upside: +298.23%
Tandem Diabetes Care
Jun 13, 2023
Maintains: Buy
Price Target: $74 → $50
Current: $16.86
Upside: +196.65%
May 12, 2023
Maintains: Buy
Price Target: $14 → $8
Current: $0.75
Upside: +970.38%
Oct 19, 2022
Downgrades: Hold
Price Target: n/a
Current: $41.59
Upside: -
Mar 28, 2022
Downgrades: Hold
Price Target: n/a
Current: $0.58
Upside: -
Jan 5, 2022
Initiates: Buy
Price Target: $11
Current: $1.83
Upside: +501.09%
Feb 3, 2021
Maintains: Buy
Price Target: $88 → $110
Current: $51.07
Upside: +115.39%
Jan 20, 2021
Downgrades: Sell
Price Target: n/a
Current: $0.61
Upside: -
Jan 11, 2021
Initiates: Buy
Price Target: $300
Current: $2.00
Upside: +14,900.00%
Aug 31, 2020
Initiates: Buy
Price Target: $28
Current: $4.88
Upside: +473.77%